Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Human Molecular Genetics

• Publication date

  1993-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/2.6.737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Enhanced therapeutic potential of a microdystrophin with an extended C-terminal domain

  2025cites this paper
• Appendicular lean mass index changes in patients with Duchenne muscular dystrophy and Becker muscular dystrophy

  2023cites this paper
• In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD Phenotype

  2023cites this paper
• Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies

  2021cites this paper
• Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy

  2020cites this paper
• The Late Endosomal Pathway Regulates the Ciliary Targeting of Tetraspanin Protein Peripherin 2

  2019cites this paper
• Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature.

  2019cites this paper
• Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

  2018cites this paper
• Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

  2018cites this paper
• Chapter 30 – Dystrophinopathies

  2015cites this paper
• MicroRNAs and Hereditary Disorders

  2013cites this paper
• Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.

  2013cites this paper
• Complement factor I deficiency: a not so rare immune defect. Characterization of new mutations and the first large gene deletion

  2012cites this paper
• Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies

  2012cites this paper
• Dystrophin: more than just the sum of its parts.

  2010cites this paper
• Petri net modelling of gene regulation of the Duchenne muscular dystrophy

  2008cites this paper
• Wide ranges of serum myostatin concentrations in Duchenne muscular dystrophy patients.

  2008cites this paper
• Uremic neuropathy: Clinical features and new pathophysiological insights

  2007cites this paper
• Calcium misregulation and the pathogenesis of muscular dystrophy.

  2007cites this paper
• Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin gene.

  2006cites this paper
• Genetic Basis of Neurologic and Neuromuscular Diseases

  2006cites this paper
• Redirecting splicing to address dystrophin mutations: molecular by-pass surgery.

  2006cites this paper
• An intragenic deletion/inversion event in the DMD gene determines a novel exon creation and results in a BMD phenotype

  2004cites this paper
• Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides.

  2004cites this paper
• Trans‐acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles

  2003cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper
• Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy

  2003cites this paper
• Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion

  2003cites this paper
• Intraoperative MRI in neurosurgery: technical overkill or the future of brain surgery?

  2003cites this paper
• Two dystrophin proteins and transcripts in a mild dystrophinopathic patient.

  2003cites this paper
• Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center.

  2003cites this paper
• The dystrophin gene is alternatively spliced throughout its coding sequence

  2002cites this paper
• Recombinant micro-genes and dystrophin viral vectors.

  2002cites this paper
• Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms

  2001cites this paper
• A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.

  2000cites this paper
• Dystrophin mutations predict cellular susceptibility to oxidative stress

  2000cites this paper
• Brain dystrophin, neurogenetics and mental retardation.

  2000cites this paper
• Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy.

  1999cites this paper
• Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing.

  1999cites this paper
• Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families.

  1998cites this paper
• Epilepsy in Duchenne and Becker muscular dystrophies.

  1997cites this paper
• Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5' region of the dystrophin gene in human skeletal muscle.

  1997cites this paper
• Duchenne phenotype with in‐frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size?

  1996cites this paper
• Some unanswered questions in Duchenne muscular dystrophy.

  1994cites this paper
• Deletion analysis of the dystrophin‐actin binding domain

  1994cites this paper
• Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice

  1994cites this paper
• Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.

  1994cites this paper
• A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient

  1993cites this paper